This is consistent with previous data that high PSMA expression in both PCa biopsies [23] and in in vivo PSMA-PET imaging [24], can serve as an independent prognostic factor for shorter recurrence free survival. The gene discussed is FOLH1; the disease is posterior cortical atrophy.